>

MEETINGS / EVENTS

RSS

May 05 - 07 2014, 12:00 AM - 12:00 AM

2014 ASA Legislative Conference

>

FDA MEDWATCH ALERTS

April 21, 2014

Lidocaine HCI Injection, USP, by Hospira: Recall - Visible Particulates

Summary:

Lidocaine HCI Injection USP by Hospira Recall Visible Particulates

April 18, 2014

Propofol Injectable Emulsion, USP by Hospira: Recall - Visible Particulates

Summary:

Propofol Injectable Emulsion USP by Hospira Recall Visible Particulates

April 18, 2014

FDA MedWatch - ARKON Anesthesia Delivery System with Version 2.0 Software by Spacelabs Healthcare: Class I Recall

Summary:

FDA MedWatch Class I Recall 4 18 14

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Anesthesiology Continuing Education (ACE) Program

SKU: 30702-14CE

... Read more »

Single Copies, Member Price: $360

ASA Highlights Quality Initiatives in Formal Comments to CMS

Tuesday, April 09, 2013

Recently, ASA submitted formal comments in response to the Centers for Medicare & Medicaid Services (CMS) Request for Information regarding the use of clinical quality measures in federal reporting programs. The CMS Request for Information was in response to Section 601(b) of the American Taxpayer Relief Act, which would allow reporting to qualified clinical data registries as satisfactory reporting data on quality measures in federal programs such as the Physician Quality Reporting System (PQRS) and the EHR Incentive Program.

Noting anesthesiologists' record as Institute of Medicine (IOM) recognized leaders in patient safety, ASA's formal comments highlighted efforts at the Anesthesia Quality Institute (AQI), including the National Anesthesia Clinical Outcomes Registry (NACOR), the Anesthesia Incident Reporting System (AIRS), the Maintenance of Certification in Anesthesiology (MOCA) Practice Performance Assessment and Improvement (PPAI) and the National Pain Registry.

Additionally, ASA responded to specific questions posed by the CMS Request for Information and ASA advocated that "specialty registries should not be limited to approved PQRS or NQF endorsed measures."

Review ASA's formal comments.

Review CMS Request for Information.

« Back to Washington Alerts